Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

421 projects found matching your search criteria :

  1. Ion exchange materials as drug carriers and dental fillers

    Call: OPUS 20 , Panel: ST5

    Principal investigator: prof. Adam Maciej Voelkel

    Politechnika Poznańska, Wydział Inżynierii Mechanicznej

  2. Make an old drug great again – isoniazid/rifamycin-boron clusters conjugates – synthesis and antitubercular activity....

    Call: OPUS 20 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Bogusława Olejniczak

    Instytut Biologii Medycznej PAN

  3. Dissecting cancer activome to develop new generation of antibody-drug conjugates

    Call: OPUS 20 (LAP) , Panel: NZ5

    Principal investigator: dr hab. Marcin Łukasz Poręba

    Politechnika Wrocławska

  4. A novel approach based on the optimized multidrug combination for glioblastoma treatment.

    Call: SONATA 16 , Panel: NZ7

    Principal investigator: prof. Małgorzata Kucińska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  5. Molecular profiling of novel antipsychotic drug candidates

    Call: OPUS 20 , Panel: NZ7

    Principal investigator: dr hab. Jan Manuel Rodriguez Parkitna

    Instytut Farmakologii PAN

  6. Development of an in vitro model for the evaluation of phototoxicity of drugs with different affinity to melanin using a...

    Call: SONATA 16 , Panel: NZ7

    Principal investigator: dr hab. Jakub Rok

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Farmaceutycznych w Sosnowcu

  7. Multifunctional smart nanostructured platforms for light-triggered wound healing polytherapy

    Call: SONATA BIS 10 , Panel: ST5

    Principal investigator: dr hab. Filippo Pierini

    Instytut Podstawowych Problemów Techniki Polska Akademia Nauk

  8. Electroporation-based manipulation of drug resistance in cancer using novel nanosecondasymmetrical pulse sequences

    Call: DAINA 2 , Panel: NZ7

    Principal investigator: dr hab. Julita Kulbacka

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Farmaceutyczny

  9. Modulation of immune cells activity in the tumor microenvironment by oligonucleotide therapeutics delivered by silk nano...

    Call: OPUS 19 , Panel: NZ6

    Principal investigator: prof. Hanna Dams-Kozłowska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  10. Drug metabolizing enzymes (DMEs) in liver pathology, proteomic characteristics, transcriptional and epigenetic regulatio...

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: prof. Marek Droździk

    Pomorski Uniwersytet Medyczny w Szczecinie

  11. Zonal thermosensitive star polymers based on steroids and saccharides as modern drug delivery systems

    Call: PRELUDIUM 19 , Panel: ST5

    Principal investigator: Paweł Misiak

    Uniwersytet w Białymstoku

  12. Combination of Molecular Simulation and Deep Learning for De Novo Drug Design

    Call: PRELUDIUM 19 , Panel: ST6

    Principal investigator: dr Tomasz Jakub Danel

    Uniwersytet Jagielloński, Wydział Matematyki i Informatyki

  13. Digestate from agricultural biogas plants as a reservoir of drug-resistance – a real risk to the environment?

    Call: PRELUDIUM 19 , Panel: NZ9

    Principal investigator: Izabela Wolak

    Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Geoinżynierii

  14. Homo- and heterometallic phosphine ruthenium and iridium complexes - design, synthesis, bioactivity and magnetic-nanofor...

    Call: PRELUDIUM 19 , Panel: ST4

    Principal investigator: Sandra Amanda Kozieł

    Uniwersytet Wrocławski, Wydział Chemii

  15. Assessment of the ability of application of folic acid and/or transferrin as alinkers between conjugates of quantum dots...

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Joanna Pilch

    Politechnika Gdańska

  16. Dual CBR1-AKR1C3 inhibitors as a new approach to improve effectiveness and safety of anthracycline therapy.

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Marek Andrzej Jamrozik

    Uniwersytet Jagielloński, Collegium Medicum

  17. Effect of the co-treatment of municipal wastewater and landfill leachate on the spread of ARGs in the environment

    Call: PRELUDIUM 19 , Panel: NZ9

    Principal investigator: Małgorzata Czatzkowska

    Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Geoinżynierii

  18. New multifunctional drug-like ligands focusing on molecular targets associated with the symptoms and causes of Alzheimer...

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Anna Marta Pasieka

    Uniwersytet Jagielloński, Collegium Medicum

  19. Evaluation of the potential use of noble metal nanoparticles as drug delivery platforms in an experimental model of infl...

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Karol Paweł Steckiewicz

    Gdański Uniwersytet Medyczny, Wydział Lekarski

  20. Novel L-asparaginases as potential therapeutic agents and antimicrobial targets: structural and functional studies of en...

    Call: OPUS 19 , Panel: NZ1

    Principal investigator: prof. Mariusz Jaskólski

    Instytut Chemii Bioorganicznej PAN

  21. Novel approach in the search for asthma and COPD therapies - computer aided design of multi-target-directed ligands bloc...

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Alicja Aleksandra Gawalska

    Uniwersytet Jagielloński, Collegium Medicum

  22. Exosome-dependent pathomechanism of dormant ovarian cancer cell awakening and growth reinforcement by normal peritoneal ...

    Call: OPUS 19 , Panel: NZ5

    Principal investigator: prof. Krzysztof Stefan Książek

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Medyczny

  23. Assessment of therapeutic value and usefulness of new generation antibiotics and their metabolites as resistance markers...

    Call: PRELUDIUM 19 , Panel: ST4

    Principal investigator: Katarzyna Joanna Pauter-Iwicka

    Uniwersytet Mikołaja Kopernika, Wydział Chemii

  24. The impact of ovarian cancer heterogeneity and microenvironment on organoid based drug sensitivity assessment

    Call: OPUS 19 , Panel: NZ5

    Principal investigator: prof. Jan Kotarski

    Uniwersytet Medyczny w Lublinie, Wydział Lekarski

  25. Amphiphilic networks derived from poly(isopropenyl-2-oxazoline) and aliphatic polyesters as multifunctional materials wi...

    Call: OPUS 19 , Panel: ST5

    Principal investigator: dr hab. Małgorzata Baśko

    Centrum Badań Molekularnych i Makromolekularnych PAN

  26. Nanofibrous mucoadhesive carrier of brinzolamide based on hydroxypropyl cellulose and β-cyclodextrin.

    Call: PRELUDIUM 18 , Panel: ST5

    Principal investigator: Olga Joanna Cegielska

    Instytut Podstawowych Problemów Techniki Polska Akademia Nauk

  27. Do potential new MRGPRX2 ligands induce mastocytes degranulation in human?

    Call: OPUS 18 , Panel: NZ5

    Principal investigator: dr hab. Grzegorz Porębski

    Uniwersytet Jagielloński, Collegium Medicum

  28. Fluorine substitution – a new algorithm for increasing biological activity

    Call: PRELUDIUM 18 , Panel: NZ7

    Principal investigator: Wojciech Pietruś

    Instytut Farmakologii PAN

  29. Seeking for CB1 and CB2 receptor ligands among drugs, drug metabolites, and phytochemical compounds

    Call: PRELUDIUM 18 , Panel: NZ7

    Principal investigator: Adam Stasiulewicz

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

  30. Building Relations and Negotiating Agency with Psychoactive Substances Among the Followers of Santo Daime in Brazil

    Call: PRELUDIUM 18 , Panel: HS3

    Principal investigator: Zuzanna Sadowska

    Instytut Archeologii i Etnologii Polskiej Akademii Nauk

  31. Trehalose releasing nanogels for autophagy stimulation

    Call: PRELUDIUM BIS 1 , Panel: ST5

    Principal investigator: dr hab. Ilona Wioletta Wandzik

    Politechnika Śląska, Wydział Chemiczny

  32. Inhalable polymeric delivery systems of antibiotics and quorum sensing inhibitors for the treatment of respiratory infec...

    Call: OPUS 18 , Panel: ST5

    Principal investigator: prof. Elżbieta Pamuła

    Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie, Wydział Inżynierii Materiałowej i Ceramiki

  33. Two in one" – novel fluorescent polymers for simultaneous imaging and drug delivery

    Call: OPUS 18 , Panel: ST5

    Principal investigator: dr hab. Agnieszka Zofia Wilczewska

    Uniwersytet w Białymstoku

  34. Comprehensive evaluation of the analytical capabilities of a capillary electrophoresis coupled with microscale thermopho...

    Call: OPUS 18 , Panel: ST4

    Principal investigator: dr hab. Paweł Mateusz Nowak

    Uniwersytet Jagielloński, Wydział Chemii

  35. "Date-rape-drug" pills as a social and analytical challenge - developing a methodology for rapid detection of psychotrop...

    Call: PRELUDIUM BIS 1 , Panel: ST4

    Principal investigator: dr hab. Renata Jolanta Wietecha-Posłuszny

    Uniwersytet Jagielloński, Wydział Chemii

  36. Modulation of exosome production to support anti-cancer treatment

    Call: OPUS 18 , Panel: NZ7

    Principal investigator: dr Liliana Monika Czernek

    Centrum Badań Molekularnych i Makromolekularnych PAN

  37. Isotope labelled ferritin - development of an alternative drug delivery system

    Call: PRELUDIUM 18 , Panel: ST4

    Principal investigator: Łukasz Cheda

    Uniwersytet Warszawski, Wydział Chemii

  38. Analysis of the conformations of organic compounds in macromolecular structures

    Call: PRELUDIUM 18 , Panel: ST6

    Principal investigator: Joanna Magdalena Macnar

    Uniwersytet Warszawski, Wydział Chemii

  39. Modified glycosaminoglycans as nanocarriers of bioactive substances

    Call: OPUS 18 , Panel: ST5

    Principal investigator: dr hab. Mariusz Kępczyński

    Uniwersytet Jagielloński, Wydział Chemii

  40. Galactosylceramide as a regulator of apoptotic gene expression and modulator of drug resistance in breast cancer cells.

    Call: OPUS 18 , Panel: NZ5

    Principal investigator: prof. Maciej Ugorski

    Uniwersytet Przyrodniczy we Wrocławiu, Wydział Medycyny Weterynaryjnej

  41. Molecular mechanisms, signal transduction and inhibition of PEBP1-15LOX protein complex triggering the ferroptotic cell ...

    Call: SONATA 15 , Panel: ST4

    Principal investigator: dr hab. Karolina Anna Mikulska-Rumińska

    Uniwersytet Mikołaja Kopernika, Wydział Fizyki, Astronomii i Informatyki Stosowanej

  42. Gankyrin protein as a new potential therapeutic target in multiple myeloma

    Call: OPUS 18 , Panel: NZ5

    Principal investigator: dr hab. Irena Misiewicz-Krzemińska

    Instytut Hematologii i Transfuzjologii

  43. Lactoferrin and versatile polymers as a tool for selective and targeted delivery of anticancer hydrophobic drugs in the ...

    Call: PRELUDIUM 18 , Panel: NZ7

    Principal investigator: Przemysław Krzysztof Gajda-Morszewski

    Uniwersytet Jagielloński, Wydział Chemii

  44. Application of cold atmospheric pressure plasmas generated in contact with a flowing liquid for direct degradation of an...

    Call: SONATA 15 , Panel: ST8

    Principal investigator: dr hab. Anna Patrycja Dzimitrowicz

    Politechnika Wrocławska

  45. Theranostic nanocarriers for drug delivery in central nervous system disorders

    Call: GRIEG 1 , Panel: ST5

    Principal investigator: prof. Piotr Warszyński

    Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

  46. Structural insights into the involvement of the RNA degradosome in trans-translation in the light of the antimicrobial a...

    Call: SONATA BIS 9 , Panel: NZ1

    Principal investigator: dr Przemysław Adam Płociński

    Uniwersytet Łódzki

  47. The use of evolutionary patterns in the optimization of chemotherapy of tuberculosis

    Call: SONATA BIS 9 , Panel: NZ6

    Principal investigator: dr Alina Ewa Minias

    Instytut Biologii Medycznej PAN

  48. The supersaturated drug delivery systems (SDDS) as a universal platform to address the problem of poor drugs' solubility

    Call: SONATA BIS 9 , Panel: NZ7

    Principal investigator: dr hab. Anna Maria Krupa

    Uniwersytet Jagielloński, Collegium Medicum

  49. Dual-targeted biodegradable polymeric micelles for anticancer drug delivery

    Call: SONATA BIS 9 , Panel: NZ7

    Principal investigator: dr Katarzyna Jelonek

    Centrum Materiałów Polimerowych i Węglowych PAN

  50. The use of olaparib and ATR / CHK1 kinase inhibitors as a targeted anti-cancer therapy based on synthetic lethality

    Call: SONATA BIS 9 , Panel: NZ7

    Principal investigator: dr hab. Aneta Katarzyna Rogalska

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy